|
WDYHV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.996200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.967400E-01 |
| Normal-vs-Stage2 |
9.118800E-01 |
| Normal-vs-Stage3 |
5.046200E-01 |
| Normal-vs-Stage4 |
6.074800E-01 |
| Stage1-vs-Stage2 |
7.288800E-01 |
| Stage1-vs-Stage3 |
8.528000E-01 |
| Stage1-vs-Stage4 |
2.626800E-01 |
| Stage2-vs-Stage3 |
6.807600E-01 |
| Stage2-vs-Stage4 |
5.884800E-01 |
| Stage3-vs-Stage4 |
2.215200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.072800E-01 |
| Normal-vs-AfricanAmerican |
9.170600E-01 |
| Normal-vs-Asian |
4.887200E-01 |
| Caucasian-vs-AfricanAmerican |
7.232200E-01 |
| Caucasian-vs-Asian |
7.601800E-01 |
| AfricanAmerican-vs-Asian |
6.524600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.985400E-01 |
| Normal-vs-Female |
9.189200E-01 |
| Male-vs-Female |
1.515030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.145400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.163800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.787000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.926800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.636600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.308200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.630800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.409800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.087400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.498600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.022000E-01 |
| Classical-VS-Follicular |
6.704400E-01 |
| Classical-VS-Other |
8.385000E-01 |
| Classical-VS-Normal |
4.597400E-01 |
| Tall-VS-Follicular |
3.054400E-01 |
| Tall-VS-Other |
3.490400E-01 |
| Tall-VS-Normal |
3.751200E-01 |
| Follicular-VS-Other |
7.887600E-01 |
| Follicular-VS-Normal |
8.433800E-01 |
| Other-VS-Normal |
6.348800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.031400E-01 |
| Normal-vs-N1 |
2.381600E-01 |
| N0-vs-N1 |
6.274600E-01 |
|
|
